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384 Comparison of cystic ﬁbrosis inpatient blood glucose monitoring
with the unit policy
L. Robb1, M. Richardson1. 1Adult CF Service, Western General Hospital,
Edinburgh, United Kingdom
The UK CF Trust Diabetes Working Group (2004) recommend blood glucose
monitoring (BGM) in all inpatients during a respiratory exacerbation (RE) and
that patients should be considered for insulin if BG levels are persistently raised.
A previous audit demonstrated suboptimal inpatient BGM in our unit resulting in
inadequate assessment & management of glycaemic status during a RE. This led
to the development of an inpatient BGM policy/documentation.
Aims: To re-audit CF inpatient BGM using the new unit policy/documentation &
highlight those requiring insulin.
Methods: From Sep-Dec 2007, all CF patients admitted with a RE underwent
BGM (n = 38). The new policy recommended BGM for the 1st 48 hrs of admission:
pre & 2 hrs post breakfast (BF), lunch (L), evening meal (EM), before bed (BB),
pre, 2 hrs into & post enteral feed (EF). All patients with persistently raised BG
>10mmol/L were assessed for insulin.
Results:Mean frequency of monitoring pre meal, post meal & BB was 69%, 34% &
47% compared with 31%, 12% & 40% prior to the new policy. Mean frequency of
pre, 2 hrs into & post EF monitoring was 60%, 65% & 35%, compared with 60%,
70% & 30% previously.
71% of patients required Diabetes Nurse input (prior status 26% NGT, 15% IGT,
59% CFRD). 59% required >48 hrs BGM. 7% commenced treatment with insulin
(50% IGT, 50% CFRD). 4% were identiﬁed as candidates for insulin, but treatment
was inappropriate due to terminal status. 15% were advised re home BGM to fully
assess need for insulin. 62% of patients already on insulin had persistently raised
BG and were advised to increase insulin dose.
Conclusion: Hyperglycaemia was evident during a RE regardless of prior glucose
tolerance status. The new BGM policy has resulted in more effective assessment &
management of glycaemic & clinical status.
385 Pilot testing of an interactive web-based meeting to replace
group workshops in a nutrition education programme “Eat Well
with CF” for adults with cystic ﬁbrosis (CF)
H.M. Watson1, C.S. Haworth1. 1Papworth Hospital, Cambridge, United Kingdom
Introduction: We have previously described the interactive nutrition education
programme “Eat Well with CF” in which group workshops were an integral part
(Watson H, Truby H, Bilton D, 2004). As a consequence of instituting individual
segregation to reduce the likelihood of cross infection, we have sought alternative
means of holding group sessions. Flashmeeting is a web based forum and we
evaluated this in 10 patients admitted to our CF ward.
Methods: Ten patients, M= 5, age range 19−39, were recruited. Patients were fully
informed and conﬁdentiality statements signed. Patients were given user guides and
pre-recorded introduction to Flashmeeting, the pilot session was conducted by the
Dietitian.
The meeting lasted 40 minutes, this included an introduction to the system, basic
nutrition education session and nutrition quiz. Patients were interviewed following
the session to complete a satisfaction questionnaire.
Results: All patients found Flashmeeting easy to use. Six were comfortable using
the webcam. 4 were not comfortable and chose to turn the webcam off, all said
they would be more comfortable at home; 5 were happy broadcasting; 5 did not like
having to speak; 9 commented that they would ﬁnd text chat preferable; 8 patients
said Flashmeeting was a good forum for groups to meet for educational purposes.
Comments included
– “Yes, this sort of meeting is deﬁnitely the way forward in CF”.
– “Considering we can’t meet as a group – it’s the next best thing”
– “More convenient than group sessions as no travel”
Conclusion: “Flashmeeting” was simple to use and a well accepted replacement
for workshops in the “Eat Well with CF” programme. There are numerous future
potential uses for “Flashmeeting” in the CF population.
386 Audit of present practice – the assessment and treatment of
CF bone health in Scotland
E.M. Thomson1. 1Dietetic, NHS Grampian, Aberdeen, United Kingdom
The UK CF Trust Bone Mineralisation Working Group published recommendations
for the assessment and treatment of bone mineralisation in CF in February 2007.
After reviewing the guidelines the Scottish CF Dietitians Group considered that the
guidelines were not being universally adhered to in Scotland and an audit of present
practice was conducted.
Method: Dietitians working in CF centres in Scotland completed a questionnaire
based on the main guideline recommendations.
Results: Data was collected from 4 adult centres and 6 paediatric centres that
provide CF care for 436 adults and 356 children.
1. DXA: In Scotland patients with CF are initially offered routine DXA scans from
age 10−18 years. 1 adult centre only offers DXA to at risk patients.
2. Calcium: All centres assess Ca intake at least annually. All paediatric centres
aim for RNI and adult centres aim for between 1000–1500mg Ca daily. The
report suggests 1300–1500mg daily from >age 8.
3. Vitamin D: All centres supplement and aim for >25−>75mmol/litre. 2 centres
would consider high dose 50,000 IU vitamin D.
4. PTH: 3 paediatric and 1 adult centre measure PTH.
5. Vitamin K: All adult centres except one routinely supplement Vitamin K if
CFKLD present and 3 paediatric centres if prothrombin time prolonged. None
prescribed vitamin K based on low BMD.
6. Bisphosphates: No children on bisophosphates. 57 adults in 4 centres on
bisophosphates varying from 8−22% of the clinic population.
7. Pubertal screening: Of the 6 paediatric centres only 2 carry out.
8. Hypogonadism: 1 of the 10 centres measures testosterone routinely and 3 centres
regularly take a menstrual history.
Conclusion: Current practice differs between centres and from recommended
practice. Centres are beginning to implement change but it is a challenge to ﬁt
more investigations into the annual review.
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Introduction: Poor nutrition in CF is associated with earlier death. CF mice have
loss of olfactory function. It is unknown if young children with CF have abnormal
taste or smell.
Aim: To assess the olfactory and gustatory function of children with CF.
Methods: Children with CF and control subjects were matched for age and sex.
Smell sensation was studied using a three-choice 16-item odour identiﬁcation
test; taste sensation was studied using a gustatory identiﬁcation test involving 5
concentrations of sweet, sour, bitter and salty tastes.
Results: 42 CF subjects: 24 males, aged 5 to 17 years (median 10 years) and 42
controls were studied. There were no differences in BMI z-score and weight. CF
subjects were shorter (CF: range (m) 1.04 to 1.79 (median 1.32) v Controls: range
1.11 to 1.94 (median 1.45) (p< 0.05). In the CF group, 3 had previous polyps
requiring surgery, 6 had allergic rhinitis and 13 were on nasal steroids.
CF subjects identiﬁed fewer odorants than controls (89.8% v 95.7% correct;
p< 0.001). 6 CF subjects and 1 control were slightly hyposmic (45−75% correct)
indicating the loss of olfactory function was mild and unlikely to be clinically
signiﬁcant. No subject was anosmic (<45% correct). No signiﬁcant differences
were found between the groups in gustatory ability (CF subjects 92.6% vs controls
94.2% correct). No correlation was found between age and odour identiﬁcation
ability, but taste performance improved with age (r = 0.39, p< 0.05) suggesting
cognition was the cause.
Discussion: CF subjects had only mild decrements in olfactory function and normal
gustatory function. Any changes in chemosensory function in CF patients under 17
years of age are mild and unlikely to contribute to poor nutrition.
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